Global Varicella Live Vaccine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Varicella zoster is also known as Human alphaherpesvirus 3 and causes chicken pox and herpes zoster in humans. The infection caused by this virus can be prevented by the use of vaccinations that are specially formulated to provide immunity against the virus. There are mainly two types of vaccinations available to provide immunity against varicella zoster such as monovalent varicella vaccine and combination varicella vaccine.
LPI (LP Information)' newest research report, the “Varicella Live Vaccine Industry Forecast” looks at past sales and reviews total world Varicella Live Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Varicella Live Vaccine sales for 2023 through 2029. With Varicella Live Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Varicella Live Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Varicella Live Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Varicella Live Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Varicella Live Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Varicella Live Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Varicella Live Vaccine.
The global Varicella Live Vaccine market size is projected to grow from US$ 2318.6 million in 2022 to US$ 2914.2 million in 2029; it is expected to grow at a CAGR of 2914.2 from 2023 to 2029.
United States market for Varicella Live Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Varicella Live Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Varicella Live Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Varicella Live Vaccine players cover Bio-Med Pvt. Limited, Changchun BCHT Biotechnology, Emcure Pharmaceuticals, GlaxoSmithKline, GC Pharma, Merck & Co. Inc., Mitsubishi Tanabe Pharma, Novo Medi Sciences and Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Varicella Live Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Varicella Live Vaccine market?
What factors are driving Varicella Live Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Varicella Live Vaccine market opportunities vary by end market size?
How does Varicella Live Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Varicella zoster is also known as Human alphaherpesvirus 3 and causes chicken pox and herpes zoster in humans. The infection caused by this virus can be prevented by the use of vaccinations that are specially formulated to provide immunity against the virus. There are mainly two types of vaccinations available to provide immunity against varicella zoster such as monovalent varicella vaccine and combination varicella vaccine.
LPI (LP Information)' newest research report, the “Varicella Live Vaccine Industry Forecast” looks at past sales and reviews total world Varicella Live Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Varicella Live Vaccine sales for 2023 through 2029. With Varicella Live Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Varicella Live Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Varicella Live Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Varicella Live Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Varicella Live Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Varicella Live Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Varicella Live Vaccine.
The global Varicella Live Vaccine market size is projected to grow from US$ 2318.6 million in 2022 to US$ 2914.2 million in 2029; it is expected to grow at a CAGR of 2914.2 from 2023 to 2029.
United States market for Varicella Live Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Varicella Live Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Varicella Live Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Varicella Live Vaccine players cover Bio-Med Pvt. Limited, Changchun BCHT Biotechnology, Emcure Pharmaceuticals, GlaxoSmithKline, GC Pharma, Merck & Co. Inc., Mitsubishi Tanabe Pharma, Novo Medi Sciences and Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Varicella Live Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Monovalent Varicella Vaccine
- Combination Varicella Vaccine
- Chickenpox Immunization
- Herpes Zoster Immunization
- Measles, Mumps, Rubella and Varicella (MMRV) Immunization
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bio-Med Pvt. Limited
- Changchun BCHT Biotechnology
- Emcure Pharmaceuticals
- GlaxoSmithKline
- GC Pharma
- Merck & Co. Inc.
- Mitsubishi Tanabe Pharma
- Novo Medi Sciences
- Sanofi
- Takeda Pharmaceutical Company Limited.
What is the 10-year outlook for the global Varicella Live Vaccine market?
What factors are driving Varicella Live Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Varicella Live Vaccine market opportunities vary by end market size?
How does Varicella Live Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Varicella Live Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Varicella Live Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Varicella Live Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Varicella Live Vaccine Segment by Type
2.2.1 Monovalent Varicella Vaccine
2.2.2 Combination Varicella Vaccine
2.3 Varicella Live Vaccine Sales by Type
2.3.1 Global Varicella Live Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Varicella Live Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Varicella Live Vaccine Sale Price by Type (2018-2023)
2.4 Varicella Live Vaccine Segment by Application
2.4.1 Chickenpox Immunization
2.4.2 Herpes Zoster Immunization
2.4.3 Measles, Mumps, Rubella and Varicella (MMRV) Immunization
2.5 Varicella Live Vaccine Sales by Application
2.5.1 Global Varicella Live Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Varicella Live Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Varicella Live Vaccine Sale Price by Application (2018-2023)
3 GLOBAL VARICELLA LIVE VACCINE BY COMPANY
3.1 Global Varicella Live Vaccine Breakdown Data by Company
3.1.1 Global Varicella Live Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Varicella Live Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Varicella Live Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Varicella Live Vaccine Revenue by Company (2018-2023)
3.2.2 Global Varicella Live Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Varicella Live Vaccine Sale Price by Company
3.4 Key Manufacturers Varicella Live Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Varicella Live Vaccine Product Location Distribution
3.4.2 Players Varicella Live Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VARICELLA LIVE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Varicella Live Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Varicella Live Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Varicella Live Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Varicella Live Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Varicella Live Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Varicella Live Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Varicella Live Vaccine Sales Growth
4.4 APAC Varicella Live Vaccine Sales Growth
4.5 Europe Varicella Live Vaccine Sales Growth
4.6 Middle East & Africa Varicella Live Vaccine Sales Growth
5 AMERICAS
5.1 Americas Varicella Live Vaccine Sales by Country
5.1.1 Americas Varicella Live Vaccine Sales by Country (2018-2023)
5.1.2 Americas Varicella Live Vaccine Revenue by Country (2018-2023)
5.2 Americas Varicella Live Vaccine Sales by Type
5.3 Americas Varicella Live Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Varicella Live Vaccine Sales by Region
6.1.1 APAC Varicella Live Vaccine Sales by Region (2018-2023)
6.1.2 APAC Varicella Live Vaccine Revenue by Region (2018-2023)
6.2 APAC Varicella Live Vaccine Sales by Type
6.3 APAC Varicella Live Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Varicella Live Vaccine by Country
7.1.1 Europe Varicella Live Vaccine Sales by Country (2018-2023)
7.1.2 Europe Varicella Live Vaccine Revenue by Country (2018-2023)
7.2 Europe Varicella Live Vaccine Sales by Type
7.3 Europe Varicella Live Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Varicella Live Vaccine by Country
8.1.1 Middle East & Africa Varicella Live Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Varicella Live Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Varicella Live Vaccine Sales by Type
8.3 Middle East & Africa Varicella Live Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Varicella Live Vaccine
10.3 Manufacturing Process Analysis of Varicella Live Vaccine
10.4 Industry Chain Structure of Varicella Live Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Varicella Live Vaccine Distributors
11.3 Varicella Live Vaccine Customer
12 WORLD FORECAST REVIEW FOR VARICELLA LIVE VACCINE BY GEOGRAPHIC REGION
12.1 Global Varicella Live Vaccine Market Size Forecast by Region
12.1.1 Global Varicella Live Vaccine Forecast by Region (2024-2029)
12.1.2 Global Varicella Live Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Varicella Live Vaccine Forecast by Type
12.7 Global Varicella Live Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bio-Med Pvt. Limited
13.1.1 Bio-Med Pvt. Limited Company Information
13.1.2 Bio-Med Pvt. Limited Varicella Live Vaccine Product Portfolios and Specifications
13.1.3 Bio-Med Pvt. Limited Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bio-Med Pvt. Limited Main Business Overview
13.1.5 Bio-Med Pvt. Limited Latest Developments
13.2 Changchun BCHT Biotechnology
13.2.1 Changchun BCHT Biotechnology Company Information
13.2.2 Changchun BCHT Biotechnology Varicella Live Vaccine Product Portfolios and Specifications
13.2.3 Changchun BCHT Biotechnology Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Changchun BCHT Biotechnology Main Business Overview
13.2.5 Changchun BCHT Biotechnology Latest Developments
13.3 Emcure Pharmaceuticals
13.3.1 Emcure Pharmaceuticals Company Information
13.3.2 Emcure Pharmaceuticals Varicella Live Vaccine Product Portfolios and Specifications
13.3.3 Emcure Pharmaceuticals Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Emcure Pharmaceuticals Main Business Overview
13.3.5 Emcure Pharmaceuticals Latest Developments
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Information
13.4.2 GlaxoSmithKline Varicella Live Vaccine Product Portfolios and Specifications
13.4.3 GlaxoSmithKline Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 GlaxoSmithKline Main Business Overview
13.4.5 GlaxoSmithKline Latest Developments
13.5 GC Pharma
13.5.1 GC Pharma Company Information
13.5.2 GC Pharma Varicella Live Vaccine Product Portfolios and Specifications
13.5.3 GC Pharma Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 GC Pharma Main Business Overview
13.5.5 GC Pharma Latest Developments
13.6 Merck & Co. Inc.
13.6.1 Merck & Co. Inc. Company Information
13.6.2 Merck & Co. Inc. Varicella Live Vaccine Product Portfolios and Specifications
13.6.3 Merck & Co. Inc. Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Merck & Co. Inc. Main Business Overview
13.6.5 Merck & Co. Inc. Latest Developments
13.7 Mitsubishi Tanabe Pharma
13.7.1 Mitsubishi Tanabe Pharma Company Information
13.7.2 Mitsubishi Tanabe Pharma Varicella Live Vaccine Product Portfolios and Specifications
13.7.3 Mitsubishi Tanabe Pharma Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Mitsubishi Tanabe Pharma Main Business Overview
13.7.5 Mitsubishi Tanabe Pharma Latest Developments
13.8 Novo Medi Sciences
13.8.1 Novo Medi Sciences Company Information
13.8.2 Novo Medi Sciences Varicella Live Vaccine Product Portfolios and Specifications
13.8.3 Novo Medi Sciences Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Novo Medi Sciences Main Business Overview
13.8.5 Novo Medi Sciences Latest Developments
13.9 Sanofi
13.9.1 Sanofi Company Information
13.9.2 Sanofi Varicella Live Vaccine Product Portfolios and Specifications
13.9.3 Sanofi Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sanofi Main Business Overview
13.9.5 Sanofi Latest Developments
13.10 Takeda Pharmaceutical Company Limited.
13.10.1 Takeda Pharmaceutical Company Limited. Company Information
13.10.2 Takeda Pharmaceutical Company Limited. Varicella Live Vaccine Product Portfolios and Specifications
13.10.3 Takeda Pharmaceutical Company Limited. Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Takeda Pharmaceutical Company Limited. Main Business Overview
13.10.5 Takeda Pharmaceutical Company Limited. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Varicella Live Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Varicella Live Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Varicella Live Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Varicella Live Vaccine Segment by Type
2.2.1 Monovalent Varicella Vaccine
2.2.2 Combination Varicella Vaccine
2.3 Varicella Live Vaccine Sales by Type
2.3.1 Global Varicella Live Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Varicella Live Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Varicella Live Vaccine Sale Price by Type (2018-2023)
2.4 Varicella Live Vaccine Segment by Application
2.4.1 Chickenpox Immunization
2.4.2 Herpes Zoster Immunization
2.4.3 Measles, Mumps, Rubella and Varicella (MMRV) Immunization
2.5 Varicella Live Vaccine Sales by Application
2.5.1 Global Varicella Live Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Varicella Live Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Varicella Live Vaccine Sale Price by Application (2018-2023)
3 GLOBAL VARICELLA LIVE VACCINE BY COMPANY
3.1 Global Varicella Live Vaccine Breakdown Data by Company
3.1.1 Global Varicella Live Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Varicella Live Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Varicella Live Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Varicella Live Vaccine Revenue by Company (2018-2023)
3.2.2 Global Varicella Live Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Varicella Live Vaccine Sale Price by Company
3.4 Key Manufacturers Varicella Live Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Varicella Live Vaccine Product Location Distribution
3.4.2 Players Varicella Live Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VARICELLA LIVE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Varicella Live Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Varicella Live Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Varicella Live Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Varicella Live Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Varicella Live Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Varicella Live Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Varicella Live Vaccine Sales Growth
4.4 APAC Varicella Live Vaccine Sales Growth
4.5 Europe Varicella Live Vaccine Sales Growth
4.6 Middle East & Africa Varicella Live Vaccine Sales Growth
5 AMERICAS
5.1 Americas Varicella Live Vaccine Sales by Country
5.1.1 Americas Varicella Live Vaccine Sales by Country (2018-2023)
5.1.2 Americas Varicella Live Vaccine Revenue by Country (2018-2023)
5.2 Americas Varicella Live Vaccine Sales by Type
5.3 Americas Varicella Live Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Varicella Live Vaccine Sales by Region
6.1.1 APAC Varicella Live Vaccine Sales by Region (2018-2023)
6.1.2 APAC Varicella Live Vaccine Revenue by Region (2018-2023)
6.2 APAC Varicella Live Vaccine Sales by Type
6.3 APAC Varicella Live Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Varicella Live Vaccine by Country
7.1.1 Europe Varicella Live Vaccine Sales by Country (2018-2023)
7.1.2 Europe Varicella Live Vaccine Revenue by Country (2018-2023)
7.2 Europe Varicella Live Vaccine Sales by Type
7.3 Europe Varicella Live Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Varicella Live Vaccine by Country
8.1.1 Middle East & Africa Varicella Live Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Varicella Live Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Varicella Live Vaccine Sales by Type
8.3 Middle East & Africa Varicella Live Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Varicella Live Vaccine
10.3 Manufacturing Process Analysis of Varicella Live Vaccine
10.4 Industry Chain Structure of Varicella Live Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Varicella Live Vaccine Distributors
11.3 Varicella Live Vaccine Customer
12 WORLD FORECAST REVIEW FOR VARICELLA LIVE VACCINE BY GEOGRAPHIC REGION
12.1 Global Varicella Live Vaccine Market Size Forecast by Region
12.1.1 Global Varicella Live Vaccine Forecast by Region (2024-2029)
12.1.2 Global Varicella Live Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Varicella Live Vaccine Forecast by Type
12.7 Global Varicella Live Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bio-Med Pvt. Limited
13.1.1 Bio-Med Pvt. Limited Company Information
13.1.2 Bio-Med Pvt. Limited Varicella Live Vaccine Product Portfolios and Specifications
13.1.3 Bio-Med Pvt. Limited Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bio-Med Pvt. Limited Main Business Overview
13.1.5 Bio-Med Pvt. Limited Latest Developments
13.2 Changchun BCHT Biotechnology
13.2.1 Changchun BCHT Biotechnology Company Information
13.2.2 Changchun BCHT Biotechnology Varicella Live Vaccine Product Portfolios and Specifications
13.2.3 Changchun BCHT Biotechnology Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Changchun BCHT Biotechnology Main Business Overview
13.2.5 Changchun BCHT Biotechnology Latest Developments
13.3 Emcure Pharmaceuticals
13.3.1 Emcure Pharmaceuticals Company Information
13.3.2 Emcure Pharmaceuticals Varicella Live Vaccine Product Portfolios and Specifications
13.3.3 Emcure Pharmaceuticals Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Emcure Pharmaceuticals Main Business Overview
13.3.5 Emcure Pharmaceuticals Latest Developments
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Information
13.4.2 GlaxoSmithKline Varicella Live Vaccine Product Portfolios and Specifications
13.4.3 GlaxoSmithKline Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 GlaxoSmithKline Main Business Overview
13.4.5 GlaxoSmithKline Latest Developments
13.5 GC Pharma
13.5.1 GC Pharma Company Information
13.5.2 GC Pharma Varicella Live Vaccine Product Portfolios and Specifications
13.5.3 GC Pharma Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 GC Pharma Main Business Overview
13.5.5 GC Pharma Latest Developments
13.6 Merck & Co. Inc.
13.6.1 Merck & Co. Inc. Company Information
13.6.2 Merck & Co. Inc. Varicella Live Vaccine Product Portfolios and Specifications
13.6.3 Merck & Co. Inc. Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Merck & Co. Inc. Main Business Overview
13.6.5 Merck & Co. Inc. Latest Developments
13.7 Mitsubishi Tanabe Pharma
13.7.1 Mitsubishi Tanabe Pharma Company Information
13.7.2 Mitsubishi Tanabe Pharma Varicella Live Vaccine Product Portfolios and Specifications
13.7.3 Mitsubishi Tanabe Pharma Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Mitsubishi Tanabe Pharma Main Business Overview
13.7.5 Mitsubishi Tanabe Pharma Latest Developments
13.8 Novo Medi Sciences
13.8.1 Novo Medi Sciences Company Information
13.8.2 Novo Medi Sciences Varicella Live Vaccine Product Portfolios and Specifications
13.8.3 Novo Medi Sciences Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Novo Medi Sciences Main Business Overview
13.8.5 Novo Medi Sciences Latest Developments
13.9 Sanofi
13.9.1 Sanofi Company Information
13.9.2 Sanofi Varicella Live Vaccine Product Portfolios and Specifications
13.9.3 Sanofi Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sanofi Main Business Overview
13.9.5 Sanofi Latest Developments
13.10 Takeda Pharmaceutical Company Limited.
13.10.1 Takeda Pharmaceutical Company Limited. Company Information
13.10.2 Takeda Pharmaceutical Company Limited. Varicella Live Vaccine Product Portfolios and Specifications
13.10.3 Takeda Pharmaceutical Company Limited. Varicella Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Takeda Pharmaceutical Company Limited. Main Business Overview
13.10.5 Takeda Pharmaceutical Company Limited. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Varicella Live Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Varicella Live Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Monovalent Varicella Vaccine
Table 4. Major Players of Combination Varicella Vaccine
Table 5. Global Varicella Live Vaccine Sales by Type (2018-2023) & (M Doses)
Table 6. Global Varicella Live Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Varicella Live Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Varicella Live Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Varicella Live Vaccine Sale Price by Type (2018-2023) & (USD/Dose)
Table 10. Global Varicella Live Vaccine Sales by Application (2018-2023) & (M Doses)
Table 11. Global Varicella Live Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Varicella Live Vaccine Revenue by Application (2018-2023)
Table 13. Global Varicella Live Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Varicella Live Vaccine Sale Price by Application (2018-2023) & (USD/Dose)
Table 15. Global Varicella Live Vaccine Sales by Company (2018-2023) & (M Doses)
Table 16. Global Varicella Live Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Varicella Live Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Varicella Live Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Varicella Live Vaccine Sale Price by Company (2018-2023) & (USD/Dose)
Table 20. Key Manufacturers Varicella Live Vaccine Producing Area Distribution and Sales Area
Table 21. Players Varicella Live Vaccine Products Offered
Table 22. Varicella Live Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Varicella Live Vaccine Sales by Geographic Region (2018-2023) & (M Doses)
Table 26. Global Varicella Live Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Varicella Live Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Varicella Live Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Varicella Live Vaccine Sales by Country/Region (2018-2023) & (M Doses)
Table 30. Global Varicella Live Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Varicella Live Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Varicella Live Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Varicella Live Vaccine Sales by Country (2018-2023) & (M Doses)
Table 34. Americas Varicella Live Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Varicella Live Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Varicella Live Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Varicella Live Vaccine Sales by Type (2018-2023) & (M Doses)
Table 38. Americas Varicella Live Vaccine Sales by Application (2018-2023) & (M Doses)
Table 39. APAC Varicella Live Vaccine Sales by Region (2018-2023) & (M Doses)
Table 40. APAC Varicella Live Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Varicella Live Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Varicella Live Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Varicella Live Vaccine Sales by Type (2018-2023) & (M Doses)
Table 44. APAC Varicella Live Vaccine Sales by Application (2018-2023) & (M Doses)
Table 45. Europe Varicella Live Vaccine Sales by Country (2018-2023) & (M Doses)
Table 46. Europe Varicella Live Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Varicella Live Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Varicella Live Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Varicella Live Vaccine Sales by Type (2018-2023) & (M Doses)
Table 50. Europe Varicella Live Vaccine Sales by Application (2018-2023) & (M Doses)
Table 51. Middle East & Africa Varicella Live Vaccine Sales by Country (2018-2023) & (M Doses)
Table 52. Middle East & Africa Varicella Live Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Varicella Live Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Varicella Live Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Varicella Live Vaccine Sales by Type (2018-2023) & (M Doses)
Table 56. Middle East & Africa Varicella Live Vaccine Sales by Application (2018-2023) & (M Doses)
Table 57. Key Market Drivers & Growth Opportunities of Varicella Live Vaccine
Table 58. Key Market Challenges & Risks of Varicella Live Vaccine
Table 59. Key Industry Trends of Varicella Live Vaccine
Table 60. Varicella Live Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Varicella Live Vaccine Distributors List
Table 63. Varicella Live Vaccine Customer List
Table 64. Global Varicella Live Vaccine Sales Forecast by Region (2024-2029) & (M Doses)
Table 65. Global Varicella Live Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Varicella Live Vaccine Sales Forecast by Country (2024-2029) & (M Doses)
Table 67. Americas Varicella Live Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Varicella Live Vaccine Sales Forecast by Region (2024-2029) & (M Doses)
Table 69. APAC Varicella Live Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Varicella Live Vaccine Sales Forecast by Country (2024-2029) & (M Doses)
Table 71. Europe Varicella Live Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Varicella Live Vaccine Sales Forecast by Country (2024-2029) & (M Doses)
Table 73. Middle East & Africa Varicella Live Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Varicella Live Vaccine Sales Forecast by Type (2024-2029) & (M Doses)
Table 75. Global Varicella Live Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Varicella Live Vaccine Sales Forecast by Application (2024-2029) & (M Doses)
Table 77. Global Varicella Live Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Bio-Med Pvt. Limited Basic Information, Varicella Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Bio-Med Pvt. Limited Varicella Live Vaccine Product Portfolios and Specifications
Table 80. Bio-Med Pvt. Limited Varicella Live Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 81. Bio-Med Pvt. Limited Main Business
Table 82. Bio-Med Pvt. Limited Latest Developments
Table 83. Changchun BCHT Biotechnology Basic Information, Varicella Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Changchun BCHT Biotechnology Varicella Live Vaccine Product Portfolios and Specifications
Table 85. Changchun BCHT Biotechnology Varicella Live Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 86. Changchun BCHT Biotechnology Main Business
Table 87. Changchun BCHT Biotechnology Latest Developments
Table 88. Emcure Pharmaceuticals Basic Information, Varicella Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Emcure Pharmaceuticals Varicella Live Vaccine Product Portfolios and Specifications
Table 90. Emcure Pharmaceuticals Varicella Live Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 91. Emcure Pharmaceuticals Main Business
Table 92. Emcure Pharmaceuticals Latest Developments
Table 93. GlaxoSmithKline Basic Information, Varicella Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. GlaxoSmithKline Varicella Live Vaccine Product Portfolios and Specifications
Table 95. GlaxoSmithKline Varicella Live Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 96. GlaxoSmithKline Main Business
Table 97. GlaxoSmithKline Latest Developments
Table 98. GC Pharma Basic Information, Varicella Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. GC Pharma Varicella Live Vaccine Product Portfolios and Specifications
Table 100. GC Pharma Varicella Live Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 101. GC Pharma Main Business
Table 102. GC Pharma Latest Developments
Table 103. Merck & Co. Inc. Basic Information, Varicella Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Merck & Co. Inc. Varicella Live Vaccine Product Portfolios and Specifications
Table 105. Merck & Co. Inc. Varicella Live Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 106. Merck & Co. Inc. Main Business
Table 107. Merck & Co. Inc. Latest Developments
Table 108. Mitsubishi Tanabe Pharma Basic Information, Varicella Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Mitsubishi Tanabe Pharma Varicella Live Vaccine Product Portfolios and Specifications
Table 110. Mitsubishi Tanabe Pharma Varicella Live Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 111. Mitsubishi Tanabe Pharma Main Business
Table 112. Mitsubishi Tanabe Pharma Latest Developments
Table 113. Novo Medi Sciences Basic Information, Varicella Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Novo Medi Sciences Varicella Live Vaccine Product Portfolios and Specifications
Table 115. Novo Medi Sciences Varicella Live Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 116. Novo Medi Sciences Main Business
Table 117. Novo Medi Sciences Latest Developments
Table 118. Sanofi Basic Information, Varicella Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Sanofi Varicella Live Vaccine Product Portfolios and Specifications
Table 120. Sanofi Varicella Live Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 121. Sanofi Main Business
Table 122. Sanofi Latest Developments
Table 123. Takeda Pharmaceutical Company Limited. Basic Information, Varicella Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Takeda Pharmaceutical Company Limited. Varicella Live Vaccine Product Portfolios and Specifications
Table 125. Takeda Pharmaceutical Company Limited. Varicella Live Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 126. Takeda Pharmaceutical Company Limited. Main Business
Table 127. Takeda Pharmaceutical Company Limited. Latest Developments
Table 1. Varicella Live Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Varicella Live Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Monovalent Varicella Vaccine
Table 4. Major Players of Combination Varicella Vaccine
Table 5. Global Varicella Live Vaccine Sales by Type (2018-2023) & (M Doses)
Table 6. Global Varicella Live Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Varicella Live Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Varicella Live Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Varicella Live Vaccine Sale Price by Type (2018-2023) & (USD/Dose)
Table 10. Global Varicella Live Vaccine Sales by Application (2018-2023) & (M Doses)
Table 11. Global Varicella Live Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Varicella Live Vaccine Revenue by Application (2018-2023)
Table 13. Global Varicella Live Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Varicella Live Vaccine Sale Price by Application (2018-2023) & (USD/Dose)
Table 15. Global Varicella Live Vaccine Sales by Company (2018-2023) & (M Doses)
Table 16. Global Varicella Live Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Varicella Live Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Varicella Live Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Varicella Live Vaccine Sale Price by Company (2018-2023) & (USD/Dose)
Table 20. Key Manufacturers Varicella Live Vaccine Producing Area Distribution and Sales Area
Table 21. Players Varicella Live Vaccine Products Offered
Table 22. Varicella Live Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Varicella Live Vaccine Sales by Geographic Region (2018-2023) & (M Doses)
Table 26. Global Varicella Live Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Varicella Live Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Varicella Live Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Varicella Live Vaccine Sales by Country/Region (2018-2023) & (M Doses)
Table 30. Global Varicella Live Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Varicella Live Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Varicella Live Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Varicella Live Vaccine Sales by Country (2018-2023) & (M Doses)
Table 34. Americas Varicella Live Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Varicella Live Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Varicella Live Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Varicella Live Vaccine Sales by Type (2018-2023) & (M Doses)
Table 38. Americas Varicella Live Vaccine Sales by Application (2018-2023) & (M Doses)
Table 39. APAC Varicella Live Vaccine Sales by Region (2018-2023) & (M Doses)
Table 40. APAC Varicella Live Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Varicella Live Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Varicella Live Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Varicella Live Vaccine Sales by Type (2018-2023) & (M Doses)
Table 44. APAC Varicella Live Vaccine Sales by Application (2018-2023) & (M Doses)
Table 45. Europe Varicella Live Vaccine Sales by Country (2018-2023) & (M Doses)
Table 46. Europe Varicella Live Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Varicella Live Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Varicella Live Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Varicella Live Vaccine Sales by Type (2018-2023) & (M Doses)
Table 50. Europe Varicella Live Vaccine Sales by Application (2018-2023) & (M Doses)
Table 51. Middle East & Africa Varicella Live Vaccine Sales by Country (2018-2023) & (M Doses)
Table 52. Middle East & Africa Varicella Live Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Varicella Live Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Varicella Live Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Varicella Live Vaccine Sales by Type (2018-2023) & (M Doses)
Table 56. Middle East & Africa Varicella Live Vaccine Sales by Application (2018-2023) & (M Doses)
Table 57. Key Market Drivers & Growth Opportunities of Varicella Live Vaccine
Table 58. Key Market Challenges & Risks of Varicella Live Vaccine
Table 59. Key Industry Trends of Varicella Live Vaccine
Table 60. Varicella Live Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Varicella Live Vaccine Distributors List
Table 63. Varicella Live Vaccine Customer List
Table 64. Global Varicella Live Vaccine Sales Forecast by Region (2024-2029) & (M Doses)
Table 65. Global Varicella Live Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Varicella Live Vaccine Sales Forecast by Country (2024-2029) & (M Doses)
Table 67. Americas Varicella Live Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Varicella Live Vaccine Sales Forecast by Region (2024-2029) & (M Doses)
Table 69. APAC Varicella Live Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Varicella Live Vaccine Sales Forecast by Country (2024-2029) & (M Doses)
Table 71. Europe Varicella Live Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Varicella Live Vaccine Sales Forecast by Country (2024-2029) & (M Doses)
Table 73. Middle East & Africa Varicella Live Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Varicella Live Vaccine Sales Forecast by Type (2024-2029) & (M Doses)
Table 75. Global Varicella Live Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Varicella Live Vaccine Sales Forecast by Application (2024-2029) & (M Doses)
Table 77. Global Varicella Live Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Bio-Med Pvt. Limited Basic Information, Varicella Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Bio-Med Pvt. Limited Varicella Live Vaccine Product Portfolios and Specifications
Table 80. Bio-Med Pvt. Limited Varicella Live Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 81. Bio-Med Pvt. Limited Main Business
Table 82. Bio-Med Pvt. Limited Latest Developments
Table 83. Changchun BCHT Biotechnology Basic Information, Varicella Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Changchun BCHT Biotechnology Varicella Live Vaccine Product Portfolios and Specifications
Table 85. Changchun BCHT Biotechnology Varicella Live Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 86. Changchun BCHT Biotechnology Main Business
Table 87. Changchun BCHT Biotechnology Latest Developments
Table 88. Emcure Pharmaceuticals Basic Information, Varicella Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Emcure Pharmaceuticals Varicella Live Vaccine Product Portfolios and Specifications
Table 90. Emcure Pharmaceuticals Varicella Live Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 91. Emcure Pharmaceuticals Main Business
Table 92. Emcure Pharmaceuticals Latest Developments
Table 93. GlaxoSmithKline Basic Information, Varicella Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. GlaxoSmithKline Varicella Live Vaccine Product Portfolios and Specifications
Table 95. GlaxoSmithKline Varicella Live Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 96. GlaxoSmithKline Main Business
Table 97. GlaxoSmithKline Latest Developments
Table 98. GC Pharma Basic Information, Varicella Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. GC Pharma Varicella Live Vaccine Product Portfolios and Specifications
Table 100. GC Pharma Varicella Live Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 101. GC Pharma Main Business
Table 102. GC Pharma Latest Developments
Table 103. Merck & Co. Inc. Basic Information, Varicella Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Merck & Co. Inc. Varicella Live Vaccine Product Portfolios and Specifications
Table 105. Merck & Co. Inc. Varicella Live Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 106. Merck & Co. Inc. Main Business
Table 107. Merck & Co. Inc. Latest Developments
Table 108. Mitsubishi Tanabe Pharma Basic Information, Varicella Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Mitsubishi Tanabe Pharma Varicella Live Vaccine Product Portfolios and Specifications
Table 110. Mitsubishi Tanabe Pharma Varicella Live Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 111. Mitsubishi Tanabe Pharma Main Business
Table 112. Mitsubishi Tanabe Pharma Latest Developments
Table 113. Novo Medi Sciences Basic Information, Varicella Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Novo Medi Sciences Varicella Live Vaccine Product Portfolios and Specifications
Table 115. Novo Medi Sciences Varicella Live Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 116. Novo Medi Sciences Main Business
Table 117. Novo Medi Sciences Latest Developments
Table 118. Sanofi Basic Information, Varicella Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Sanofi Varicella Live Vaccine Product Portfolios and Specifications
Table 120. Sanofi Varicella Live Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 121. Sanofi Main Business
Table 122. Sanofi Latest Developments
Table 123. Takeda Pharmaceutical Company Limited. Basic Information, Varicella Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Takeda Pharmaceutical Company Limited. Varicella Live Vaccine Product Portfolios and Specifications
Table 125. Takeda Pharmaceutical Company Limited. Varicella Live Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 126. Takeda Pharmaceutical Company Limited. Main Business
Table 127. Takeda Pharmaceutical Company Limited. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Varicella Live Vaccine
Figure 2. Varicella Live Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Varicella Live Vaccine Sales Growth Rate 2018-2029 (M Doses)
Figure 7. Global Varicella Live Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Varicella Live Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Monovalent Varicella Vaccine
Figure 10. Product Picture of Combination Varicella Vaccine
Figure 11. Global Varicella Live Vaccine Sales Market Share by Type in 2022
Figure 12. Global Varicella Live Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Varicella Live Vaccine Consumed in Chickenpox Immunization
Figure 14. Global Varicella Live Vaccine Market: Chickenpox Immunization (2018-2023) & (M Doses)
Figure 15. Varicella Live Vaccine Consumed in Herpes Zoster Immunization
Figure 16. Global Varicella Live Vaccine Market: Herpes Zoster Immunization (2018-2023) & (M Doses)
Figure 17. Varicella Live Vaccine Consumed in Measles, Mumps, Rubella and Varicella (MMRV) Immunization
Figure 18. Global Varicella Live Vaccine Market: Measles, Mumps, Rubella and Varicella (MMRV) Immunization (2018-2023) & (M Doses)
Figure 19. Global Varicella Live Vaccine Sales Market Share by Application (2022)
Figure 20. Global Varicella Live Vaccine Revenue Market Share by Application in 2022
Figure 21. Varicella Live Vaccine Sales Market by Company in 2022 (M Doses)
Figure 22. Global Varicella Live Vaccine Sales Market Share by Company in 2022
Figure 23. Varicella Live Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Varicella Live Vaccine Revenue Market Share by Company in 2022
Figure 25. Global Varicella Live Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Varicella Live Vaccine Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Varicella Live Vaccine Sales 2018-2023 (M Doses)
Figure 28. Americas Varicella Live Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. APAC Varicella Live Vaccine Sales 2018-2023 (M Doses)
Figure 30. APAC Varicella Live Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Europe Varicella Live Vaccine Sales 2018-2023 (M Doses)
Figure 32. Europe Varicella Live Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Varicella Live Vaccine Sales 2018-2023 (M Doses)
Figure 34. Middle East & Africa Varicella Live Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Americas Varicella Live Vaccine Sales Market Share by Country in 2022
Figure 36. Americas Varicella Live Vaccine Revenue Market Share by Country in 2022
Figure 37. Americas Varicella Live Vaccine Sales Market Share by Type (2018-2023)
Figure 38. Americas Varicella Live Vaccine Sales Market Share by Application (2018-2023)
Figure 39. United States Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Varicella Live Vaccine Sales Market Share by Region in 2022
Figure 44. APAC Varicella Live Vaccine Revenue Market Share by Regions in 2022
Figure 45. APAC Varicella Live Vaccine Sales Market Share by Type (2018-2023)
Figure 46. APAC Varicella Live Vaccine Sales Market Share by Application (2018-2023)
Figure 47. China Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Varicella Live Vaccine Sales Market Share by Country in 2022
Figure 55. Europe Varicella Live Vaccine Revenue Market Share by Country in 2022
Figure 56. Europe Varicella Live Vaccine Sales Market Share by Type (2018-2023)
Figure 57. Europe Varicella Live Vaccine Sales Market Share by Application (2018-2023)
Figure 58. Germany Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Varicella Live Vaccine Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Varicella Live Vaccine Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Varicella Live Vaccine Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Varicella Live Vaccine Sales Market Share by Application (2018-2023)
Figure 67. Egypt Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Varicella Live Vaccine in 2022
Figure 73. Manufacturing Process Analysis of Varicella Live Vaccine
Figure 74. Industry Chain Structure of Varicella Live Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Varicella Live Vaccine Sales Market Forecast by Region (2024-2029)
Figure 77. Global Varicella Live Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Varicella Live Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Varicella Live Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Varicella Live Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Varicella Live Vaccine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Varicella Live Vaccine
Figure 2. Varicella Live Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Varicella Live Vaccine Sales Growth Rate 2018-2029 (M Doses)
Figure 7. Global Varicella Live Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Varicella Live Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Monovalent Varicella Vaccine
Figure 10. Product Picture of Combination Varicella Vaccine
Figure 11. Global Varicella Live Vaccine Sales Market Share by Type in 2022
Figure 12. Global Varicella Live Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Varicella Live Vaccine Consumed in Chickenpox Immunization
Figure 14. Global Varicella Live Vaccine Market: Chickenpox Immunization (2018-2023) & (M Doses)
Figure 15. Varicella Live Vaccine Consumed in Herpes Zoster Immunization
Figure 16. Global Varicella Live Vaccine Market: Herpes Zoster Immunization (2018-2023) & (M Doses)
Figure 17. Varicella Live Vaccine Consumed in Measles, Mumps, Rubella and Varicella (MMRV) Immunization
Figure 18. Global Varicella Live Vaccine Market: Measles, Mumps, Rubella and Varicella (MMRV) Immunization (2018-2023) & (M Doses)
Figure 19. Global Varicella Live Vaccine Sales Market Share by Application (2022)
Figure 20. Global Varicella Live Vaccine Revenue Market Share by Application in 2022
Figure 21. Varicella Live Vaccine Sales Market by Company in 2022 (M Doses)
Figure 22. Global Varicella Live Vaccine Sales Market Share by Company in 2022
Figure 23. Varicella Live Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Varicella Live Vaccine Revenue Market Share by Company in 2022
Figure 25. Global Varicella Live Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Varicella Live Vaccine Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Varicella Live Vaccine Sales 2018-2023 (M Doses)
Figure 28. Americas Varicella Live Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. APAC Varicella Live Vaccine Sales 2018-2023 (M Doses)
Figure 30. APAC Varicella Live Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Europe Varicella Live Vaccine Sales 2018-2023 (M Doses)
Figure 32. Europe Varicella Live Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Varicella Live Vaccine Sales 2018-2023 (M Doses)
Figure 34. Middle East & Africa Varicella Live Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Americas Varicella Live Vaccine Sales Market Share by Country in 2022
Figure 36. Americas Varicella Live Vaccine Revenue Market Share by Country in 2022
Figure 37. Americas Varicella Live Vaccine Sales Market Share by Type (2018-2023)
Figure 38. Americas Varicella Live Vaccine Sales Market Share by Application (2018-2023)
Figure 39. United States Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Varicella Live Vaccine Sales Market Share by Region in 2022
Figure 44. APAC Varicella Live Vaccine Revenue Market Share by Regions in 2022
Figure 45. APAC Varicella Live Vaccine Sales Market Share by Type (2018-2023)
Figure 46. APAC Varicella Live Vaccine Sales Market Share by Application (2018-2023)
Figure 47. China Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Varicella Live Vaccine Sales Market Share by Country in 2022
Figure 55. Europe Varicella Live Vaccine Revenue Market Share by Country in 2022
Figure 56. Europe Varicella Live Vaccine Sales Market Share by Type (2018-2023)
Figure 57. Europe Varicella Live Vaccine Sales Market Share by Application (2018-2023)
Figure 58. Germany Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Varicella Live Vaccine Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Varicella Live Vaccine Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Varicella Live Vaccine Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Varicella Live Vaccine Sales Market Share by Application (2018-2023)
Figure 67. Egypt Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Varicella Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Varicella Live Vaccine in 2022
Figure 73. Manufacturing Process Analysis of Varicella Live Vaccine
Figure 74. Industry Chain Structure of Varicella Live Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Varicella Live Vaccine Sales Market Forecast by Region (2024-2029)
Figure 77. Global Varicella Live Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Varicella Live Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Varicella Live Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Varicella Live Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Varicella Live Vaccine Revenue Market Share Forecast by Application (2024-2029)
